Immunoassay Interferences & Their Impact on Patient Care

In this session our industry experts review how the common immunoassay formats work, how the different types of interference mechanisms cause falsely elevated and suppressed results for each assay format, how these interferences may impact patient care and outcomes, and how current strategies are used to troubleshoot interference.

Presenters:

  • Nikola Baumann, PhD, DABCC, Co-Director Central Clinical Laboratory and Central Processing at Mayo Clinic in Rochester, MN

  • Brooke Katzman, PhD, DABCC, Co-Director of the Hospital Clinical Lab and Point of Care Testing at Mayo Clinic in Rochester, MN

  • Pr. Damien Gruson, PhD, EuSpLM, FESC, Chef du Service de Biochimie Médicale in Bruxelles – Belgique

Previous
Previous

The FDA Warns that Biotin Interferes with Troponin Lab Tests

Next
Next

Veravas Featured in the Minneapolis/St. Paul Business Journal